Hydroxychloroquine Failed Treatment for Corona Patients

The American media released on Friday the details of a documented study published about a new treatment for the emerging coronavirus, or Covid 19, that has been shown to be ineffective with the disease.

A new study conducted by hospitals in New York revealed that giving corona patients, hydroxychloroquine,that used to treat malaria, did not improve their condition or make it worse.

The authors of the study, which was published in the New England Journal of Medicine, said that “the risk of death or insertion of a tube into the trachea in patients who received hydrochloroquine compared to those who did not receive it did not decrease or increase significantly.”

A monitoring study, funded by the American Institutes of Health, was conducted on Covid-19 patients admitted to the emergency department of two hospitals in New York.

811 patients received two doses of 600 mg of hydroxychloroquine on the first day, and then 400 mg daily, over a period of four days, and 565 patients did not receive the drug.

Scientists stressed that this study “should not be used to exclude” the pros or possible risks of hydroxychloroquine therapy.

They added: “However, our results do not support the use of hydroxychloroquine at present outside of randomized clinical trials to demonstrate its effectiveness.”

US President Donald Trump has regularly supported the use of hydroxychloroquine as a treatment for Covid-19 patients, but US and Canadian health authorities have warned against using it outside of clinical trials.

For years, hydroxychloroquine and chlorine have been used to treat malaria and some autoimmune diseases, such as lupus and rheumatoid arthritis.